Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP
Pathology and Oncology Research - Netherlands
doi 10.1007/s12253-010-9304-4
Full Text
Open PDFAbstract
Available in full text
Date
September 18, 2010
Authors
Publisher
Springer Science and Business Media LLC